Accordingly, similarly to RRMS, elevated CSF CXCL13 levels have been associated with disease activity, increased CSF cell counts, IgG-index and MBP, NFL and CHI3L1 concentrations in progressive MS (both PPMS and SPMS) as well [183,184]. Here, CXCL13 is linked to myeloid sarcoma.